FIELD: medicine, pharmacy. SUBSTANCE: invention relates to a pharmaceutical composition for controlled release that comprises a medicinal agent, polyethylene oxide with molecular mass 2000000 Da or above and a special size-regulating agent for indicated polyethylene oxide and wherein indicated medicinal agent and size-regulating agent are dispersed uniformly in polyethylene oxide.
Шаровая мельница классификатор. Линии для производства микропорошков (с размером частиц 2-5 мкм) Горная техника и обогатительное оборудование >
The Diabetes Prevention Program (DPP) was a 27-center randomized clinical trial to determine whether lifestyle intervention or pharmacological therapy (metformin) would prevent or delay the onset of diabetes in individuals with impaired glucose tolerance (IGT) who are at high risk for the disease ().Recently, it was reported that both the lifestyle intervention and metformin were effective in ...